Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD43/Sialophorin Antibody (SPN/1094), Novus Biologicals™

Mouse Monoclonal Antibody
$268.00 - $524.00
Specifications
Antigen | CD43/Sialophorin |
---|---|
Clone | SPN/1094 |
Concentration | 0.2mg/mL |
Dilution | Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml, Immunofluorescence 1 - 2 ug/ml |
Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP24465100
![]() |
Novus Biologicals
NBP2446510.02MG |
0.02 mg |
Each for $268.00
|
|
|||||
NBP24465101
![]() |
Novus Biologicals
NBP2446510.1MG |
0.1 mg |
Each for $524.00
|
|
|||||
NBP24465102
![]() |
Novus Biologicals
NBP2446510.2MG |
0.2 mg | N/A | N/A | N/A | ||||
Description
Ensure accurate, reproducible results in Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
CD43/Sialophorin Monoclonal specifically detects CD43/Sialophorin in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
CD43/Sialophorin | |
0.2mg/mL | |
Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence | |
Unconjugated | |
Mouse | |
Immunology | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
CD43 antigen, CD43), Galactoglycoprotein, GALGP, Leukocyte sialoglycoprotein, Sialophorin, sialophorin (gpL115, leukosialin, CD43) | |
SPN | |
IgG1 κ | |
Protein A or G purified | |
It recognizes a cell surface glycoprotein of 95/115/135kDa (depending upon the extent of glycosylation), identified as CD43. 70-90% of T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be a malignant lymphoma, especially a low-grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma. |
SPN/1094 | |
Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml, Immunofluorescence 1 - 2 ug/ml | |
Monoclonal | |
Purified | |
RUO | |
Human | |
P16150 | |
6693 | |
Recombinant human SPN protein | |
Primary | |
Store at 4C. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title